Advertisement

Related Videos

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Varsha Gandhi, PhD, on Ibrutinib

Peter Clark, MA, MD, FRCP: A Payer Perspective

David A. Hyman, MD, JD, on Inclusive Shared Savings

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Advertisement

Advertisement




May
30
Today In Oncology
After the Founder: What a Cervical Cancer Program in Haiti Teaches About Sustaining Prevention
Pain and Health-Related QOL With Darolutamide in Metastatic Hormone-Sensitive Prostate Cancer
Lymph Node Surgery and CDK4/6 Inhibitor Treatment in Early Breast Cancer
ASCO Collaborates With Ryght AI to Accelerate Site Selection for Metastatic Breast Cancer Trial
Behind the Scenes of the 2026 ASCO Annual Meeting
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo